ARK Genomic Revolution ETF
ARKG
414 hedge funds and large institutions have $1.83B invested in ARK Genomic Revolution ETF in 2020 Q4 according to their latest regulatory filings, with 191 funds opening new positions, 156 increasing their positions, 44 reducing their positions, and 16 closing their positions.
1,094% more first-time investments, than exits
New positions opened: 191 | Existing positions closed: 16
255% more repeat investments, than reductions
Existing positions increased: 156 | Existing positions reduced: 44
238% more funds holding in top 10
Funds holding in top 10: 8 → 27 (+19)
141% more capital invested
Capital invested by funds: $761M → $1.83B (+$1.07B)
70% more funds holding
Funds holding: 243 → 414 (+171)
9.05% less ownership
Funds ownership: 33.59% → 24.54% (-9%)
55% less call options, than puts
Call options by funds: $186M | Put options by funds: $411M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$59.2M |
| 2 |
Morgan Stanley
New York
|
+$51.7M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$48.7M |
| 4 |
LPL Financial
San Diego,
California
|
+$33.1M |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$22.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CFA
Carroll Financial Associates
Charlotte,
North Carolina
|
-$6.63M |
| 2 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$4.5M |
| 3 |
LFA
Legend Financial Advisors
Pittsburgh,
Pennsylvania
|
-$3.67M |
| 4 |
AWMS
Advocacy Wealth Management Services
Atlanta,
Georgia
|
-$3.01M |
| 5 |
PP
Prudential plc
London, England,
United Kingdom
|
-$2.86M |
ARKG Hedge Fund Activity: Q4 2020 in Review
414 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q4 2020, worth a combined $1.83B — up 141% from $761M a quarter earlier.
Buyers outnumbered sellers: 191 funds opened new ARKG positions and 16 closed out — a net gain of 175 holders — while 156 added to existing stakes and 44 trimmed.
The largest buyer was Jane Street, adding an estimated $59.2M. The largest seller was Carroll Financial Associates, cutting an estimated $6.63M.
- 414 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q4 2020, up from 243 in Q3 2020.
- Funds reported $1.83B of ARK Genomic Revolution ETF stock for Q4 2020, up 141% quarter-over-quarter.
- 191 funds opened new ARK Genomic Revolution ETF positions in Q4 2020 and 16 closed out, a net change of +175 holders.
- The largest ARK Genomic Revolution ETF buyer in Q4 2020 was Jane Street, an estimated $59.2M added.
- The largest ARK Genomic Revolution ETF seller in Q4 2020 was Carroll Financial Associates, an estimated $6.63M sold.
Based on aggregated 13F filings for Q4 2020.